Τετάρτη 10 Μαΐου 2017

A late setback for atezolizumab to treat bladder cancer, only a month after @US_FDA accelerated first line approval… https://t.co/CGXiat5YU5

A late setback for atezolizumab to treat bladder cancer, only a month after @US_FDA accelerated first line approval… https://t.co/CGXiat5YU5

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/862321791209013248
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις